Display options
Cite
Bang SL, Png KS, Yeow YY, et al. Developing technical expertise in robot-assisted laparoscopic prostatectomy in a moderate-volume center through a proctor-based team approach. J Robot Surg. 2014;8(3):245-50doi: 10.1007/s11701-014-0460-5.
Bang, S. L., Png, K. S., Yeow, Y. Y., Tan, G. Y., & Chong, Y. L. (2014). Developing technical expertise in robot-assisted laparoscopic prostatectomy in a moderate-volume center through a proctor-based team approach. Journal of robotic surgery, 8(3), 245-50. https://doi.org/10.1007/s11701-014-0460-5
Bang, Shieh Ling, et al. "Developing technical expertise in robot-assisted laparoscopic prostatectomy in a moderate-volume center through a proctor-based team approach." Journal of robotic surgery vol. 8,3 (2014): 245-50. doi: https://doi.org/10.1007/s11701-014-0460-5
Bang SL, Png KS, Yeow YY, Tan GY, Chong YL. Developing technical expertise in robot-assisted laparoscopic prostatectomy in a moderate-volume center through a proctor-based team approach. J Robot Surg. 2014 Sep;8(3):245-50. doi: 10.1007/s11701-014-0460-5. Epub 2014 Apr 20. PMID: 27637685.
Copy Download .nbib Format: NLM
Share it on

J Robot Surg. 2014 Sep;8(3):245-50. doi: 10.1007/s11701-014-0460-5. Epub 2014 Apr 20.

Developing technical expertise in robot-assisted laparoscopic prostatectomy in a moderate-volume center through a proctor-based team approach.

Journal of robotic surgery

Shieh Ling Bang, Keng Siang Png, Yu Yi Yeow, Gerald Yau Min Tan, Yew Lam Chong

Affiliations

  1. Tan Tock Seng Hospital, Singapore, Singapore.
  2. Mount Elizabeth Medical Centre, Singapore, Singapore.
  3. Tan Tock Seng Hospital, Singapore, Singapore. [email protected].

PMID: 27637685 DOI: 10.1007/s11701-014-0460-5

Abstract

Our aim is to report our preliminary experience of a proctor-based team approach in robot-assisted laparoscopic prostatectomy (RALP) for the treatment of localized prostate cancer. Data was collected between December 2008 and February 2012. RALP was performed on 100 consecutive patients with prostate cancer by a team of five urologists proctored by two fellowship-trained surgeons from a single hospital. Clinical and pathological data of these patients were reviewed. The mean age of the patients was 66 years (range 48-76). Clinical stages were 82 % cT1c, 3 % cT1b, 13 % cT2a and 2 % cT3a disease. Preoperative mean prostate-specific antigen level was 11.33 ng/ml (SD 10.47). Mean operative time was 342 min and mean blood loss was 717 ml (SD 988). Mean hospital stay and duration of the indwelling catheter were 3.2 days (SD 1.8) and 12.6 days (SD 8.5), respectively. Pathological staging showed 65 patients with pT2a (65 %) disease and 33 patients with pT3a (33 %) disease. Thirty-five patients (35 %) had positive surgical margins. Eighteen patients underwent adjuvant radiotherapy. Overall postoperative complication rate was 14 %. There were six Clavien grade 1 complications, seven Clavien grade 2 complications and one Clavien grade 3 complication. At mean follow-up of 36 months, 100 % of patients remained free of biochemical recurrence with continence at 70 %. Our proctor-based team approach will continue to improve each surgeon's technical competency. He or she will continue to improve and gradually move on to achieving his or her outcomes learning curve.

Keywords: Laparoscopy; Prostate; Prostate cancer; Prostatectomy; Robotics; Surgical procedures, minimally invasive; Urology

References

  1. Eur Urol. 2007 Jan;51(1):45-55; discussion 56 - PubMed
  2. Urol J. 2007 Summer;4(3):130-7 - PubMed
  3. Asian J Surg. 2004 Oct;27(4):321-5 - PubMed
  4. Int Braz J Urol. 2008 May-Jun;34(3):259-68; discussion 268-9 - PubMed
  5. BJU Int. 2005 Jan;95(1):183-6 - PubMed
  6. BJU Int. 2010 Apr;105(8):1148-54 - PubMed
  7. J Urol. 2011 Apr;185(4):1191-7 - PubMed
  8. Int J Urol. 2006 May;13(5):560-4 - PubMed
  9. Urology. 2003 Apr;61(4):699-702 - PubMed
  10. Expert Rev Anticancer Ther. 2010 May;10(5):671-82 - PubMed
  11. Eur Urol. 2007 Mar;51(3):648-57; discussion 657-8 - PubMed
  12. J Urol. 2000 Jun;163(6):1643-9 - PubMed
  13. J Endourol. 2008 Apr;22(4):587-9; discussion 589-90 - PubMed
  14. Curr Opin Urol. 2010 Jan;20(1):80-5 - PubMed
  15. J Endourol. 2003 Nov;17(9):785-90 - PubMed
  16. J Urol. 2009 Sep;182(3):1126-32 - PubMed
  17. CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 - PubMed
  18. Urology. 2005 Nov;66(5 Suppl):105-7 - PubMed
  19. JAMA. 1993 Aug 25;270(8):948-54 - PubMed
  20. J Clin Oncol. 2002 Dec 1;20(23):4567-73 - PubMed
  21. Urology. 2006 Jul;68(1):75-9 - PubMed
  22. J Endourol. 2008 Oct;22(10):2299-305 - PubMed
  23. J Endourol. 2013 Jan;27(1):80-5 - PubMed
  24. Am J Surg Pathol. 1996 Mar;20(3):286-92 - PubMed

Publication Types